Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
12/9/2022
Drug R&D and Product Registration News Digest December 2022 (1)
12/8/2022
Sinopharm Considering Bid to Take China TCM for $4B: Bloomberg
12/8/2022
China's Reversal of Zero-Covid Policy to Boost Its Healthcare Sector: ...
12/8/2022
November Sees Several Approvals for China-developed Drugs (PharmaDJ)
12/7/2022
54 Drugs Greenlighted Since Conditional Approval Implemented in China ...
12/6/2022
NHSA Announces Postponement of On-Site Negotiations for the 2022 NRDL
12/6/2022
Summit and Akeso Reached ~$5B In-License Deal for Breakthru Innovative...
12/5/2022
Incyte Forms Partnership with CMS for Ruxolitinib Cream in Greater Chi...
12/5/2022
Joint Fight Against Cancer Can Help Re-Energize U.S.-China Ties: Asia ...
12/2/2022
CDE Issues Notice on Requirements for e-Submission of Drug Registratio...
12/2/2022
Catalent Expands Clinical Supply Facility in China's FTZ
12/2/2022
HanAll's Licensed Partner in China Enters Sublicense Agreement with CS...
12/2/2022
Recent Executive Moves
12/2/2022
China's Challenge in the Drug Services Field (C&EN)
12/1/2022
A Growing Number of Drugmakers in China Are on A Quest to Treat NASH (...
12/1/2022
Eli Lilly Dumps Innovent's PD-1 after FDA Rebuff (FiercePharma)
12/1/2022
NMPA Solicits Comments on the Provisions on Facilitating Main Responsi...
11/30/2022
WuXi STA Launches Another Parenteral Formulation Manufacturing Line at...
11/30/2022
NMPA Issues Appendix 6 for Quality Control of Drug Retail Delivery of ...
11/30/2022
NMPA Issues the Announcement on Implementation of Electronic Submissio...
11/30/2022
NMPA Issues the List of Drugs Prohibited for Online Sales (Unofficial ...
11/30/2022
NMPA Issues the Announcement on Regulating the Filing and Reporting of...
11/30/2022
XJTLU and University of Liverpool to Inaugurate Joint Pharma R&D Cente...
11/30/2022
Financial-related Company News Digest (November 2022)
11/30/2022
Population Ageing in China: Crisis or Opportunity? (The Lancet)
11/30/2022
Nowcasting and Forecasting the Care Needs of the Older Population in C...
11/30/2022
Chinese Pharma Recovery Face Pressure as Covid Surges to A New Peak
11/29/2022
A Slow October Sees Deals in Novel Therapies with New Technologies (Ph...
11/29/2022
DB6: Strong Global CHC Growth Continues in MAT Q2/2022, As China Sales...
11/29/2022
Nicholas Hall Reports Growth of Chinese OTC Dermatologicals Market in ...
Page:
63
/
719
Total number of articles:
21546
:
[First]
[<<]
[61]
[62]
[63]
[64]
[65]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit